mizoribine has been researched along with Nephrotic Syndrome in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (9.52) | 18.2507 |
| 2000's | 18 (42.86) | 29.6817 |
| 2010's | 17 (40.48) | 24.3611 |
| 2020's | 3 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Fujinaga, S; Hirano, D; Morishita, T; Onuki, Y; Sakuraya, K; Takemasa, Y | 1 |
| Fujinaga, S; Mizutani, A | 1 |
| Itabashi, M; Matsuno, S; Sugimoto, H; Takei, T; Yamanaka, N; Yumura, W | 1 |
| Manabe, S; Nagata, M; Nitta, K | 1 |
| Fujinaga, S; Hirano, D; Mizutani, A; Sakuraya, K; Shimizu, T | 1 |
| Aoyagi, H; Ariga, T; Hayashi, A; Kobayashi, N; Nakanishi, M; Okamoto, T; Sato, Y; Takahashi, T; Ueno, M; Uetake, K; Yamazaki, T | 1 |
| Hama, T; Iijima, K; Ishikura, K; Ito, S; Nakamura, H; Nakanishi, K; Nozu, K; Saito-Oba, M; Sako, M; Shima, Y; Yoshikawa, N | 1 |
| Dang, XQ; Gao, YF; Jiang, XY; Rong, LP; Shen, Q; Xia, ZK; Xu, H; Yi, ZW | 1 |
| Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H | 1 |
| Matsumoto, Y; Moriki, T; Nojima, Y; Shimada, Y | 1 |
| Craig, JC; Hodson, EM; Pravitsitthikul, N; Willis, NS | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Ji, Y; Li, W; Liu, J; Sun, J; Wang, J; Yong, Q; Zhang, H; Zhang, K; Zhang, W | 1 |
| Doi, T; Kawai, T; Masaki, T; Shiraki, N; Yorioka, N | 1 |
| Kawasaki, Y | 1 |
| Hara, Y; Hashimoto, Y; Hosoya, T; Ito, H; Miyazaki, Y; Okonogi, H; Utsunomiya, Y | 1 |
| Mitarai, T | 1 |
| Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T | 1 |
| Aizawa-Yashiro, T; Ito, E; Oki, E; Tanaka, H; Tsuruga, K; Watanabe, S | 1 |
| Endo, A; Fujinaga, S; Hirano, D; Kaneko, K; Ohtomo, Y; Shimizu, T; Watanabe, T | 1 |
| Benndorf, R; Greenbaum, LA; Smoyer, WE | 1 |
| Fujieda, M; Hayashi, A; Ishihara, M; Morita, T; Ohta, T; Okada, S; Sakano, T; Wakiguchi, H | 1 |
| Kurokawa, K; Mitarai, T; Nishi, S; Saito, T; Sakai, H; Shiiki, H; Yokoyama, H; Yorioka, N; Yoshimura, A | 1 |
| Arakawa, M; Harada, T; Hishida, A; Ishida, M; Ishikawa, I; Kashihara, N; Kobayashi, Y; Koike, T; Koyama, A; Maeda, K; Makino, H; Mitarai, T; Muso, E; Nagasawa, T; Nagase, M; Nojima, Y; Osawa, G; Saito, T; Sakai, O; Sato, H; Sato, M; Shibasaki, T; Shiiki, H; Sugisaki, T; Tomino, Y; Tomita, K; Yamabe, H; Yorioka, N | 1 |
| Takeda, Y; Tomino, Y | 1 |
| Isome, M; Kawasaki, Y; Nozawa, R; Suzuki, H; Suzuki, J; Takahashi, A | 1 |
| Ito, E; Kimura, S; Kudo, M; Nakahata, T; Onuma, S; Tanaka, H; Tsugawa, K | 1 |
| Hosoya, M; Isome, M; Kawasaki, Y; Kobayashi, S; Ohara, S; Onishi, N; Suzuki, H; Takahashi, A | 1 |
| Akashi, S; Fujinaga, S; Kaneko, K; Murakami, H; Ohtomo, Y; Shimizu, T; Takada, M; Yamashiro, Y | 1 |
| Honda, M; Iijima, I; Ikeda, M; Nakamura, H; Nakanishi, K; Ootomo, Y; Sako, M; Sekine, K; Wada, N; Yoshikawa, N | 1 |
| Goto, M; Hamasaki, Y; Hataya, H; Honda, M; Ikeda, M; Ishikura, K | 1 |
| Hashimoto, K; Hosoya, M; Imaizumi, T; Kawasaki, Y; Matsumoto, A; Matsuura, H; Suyama, K; Suzuki, H; Takano, K | 1 |
| Bessho, F; Hagiwara, E; Kawakami, H; Khoshnoodi, J; Kurayama, R; Nakajo, A; Sekine, Y; Swiatecka-Urban, A; Takahashi, S; Takenaka, H; Tryggvason, K; Watanabe, T; Yan, K | 1 |
| Fukuda, W; Hamaguchi, M; Ishino, H; Kadoya, M; Kawahito, Y; Kohno, M; Niimi, M; Tsubouchi, Y; Wada, M; Yamamoto, A; Yoshikawa, T | 1 |
| Craig, JC; Hodson, EM; Willis, NS | 1 |
| Fujieda, M; Hayashi, A; Ishihara, M; Morita, T; Ohta, T; Sakano, T; Utsunomiya, Y; Wakiguchi, H | 1 |
| Igarashi, Y; Inoue, CN; Kondo, Y; Moro, Y | 1 |
| Endo, T; Horata-Takahashi, E; Kamata, K; Kobayashi, Y; Kumano, K; Nakayama, Y; Okubo, M; Osakabe, T; Sato, K; Tamura, K | 1 |
| Hamasaki, T; Kinoshita, Y; Mori, M; Saeki, T; Sakano, T | 1 |
| Ishikawa, H | 1 |
| Ito, H; Maki, S; Nakamura, H; Ohashi, Y; Sakai, T; Tanizawa, T; Wada, H; Yoshikawa, N; Yoshioka, K | 1 |
| Honda, M | 1 |
11 review(s) available for mizoribine and Nephrotic Syndrome
| Article | Year |
|---|---|
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2018 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Infant; Levamisole; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Ribonucleosides; Secondary Prevention | 2013 |
Mizoribine: a new approach in the treatment of renal disease.
Topics: Adolescent; Adult; Child; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Ribonucleosides; Treatment Outcome | 2009 |
[Immunosuppressive therapies for refractory nephrotic syndrome].
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Polymorphism, Genetic; Ribonucleosides; Rituximab; Tacrolimus | 2010 |
Childhood nephrotic syndrome--current and future therapies.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Cyclosporine; Enzyme Inhibitors; Galactose; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-13; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mycophenolic Acid; Nephrotic Syndrome; p38 Mitogen-Activated Protein Kinases; Plasmapheresis; Protein Serine-Threonine Kinases; Receptors, Notch; Ribonucleosides; Rituximab; Signal Transduction; Tacrolimus; Thiazolidinediones; Unfolded Protein Response | 2012 |
[Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].
Topics: Blood Component Removal; Cause of Death; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Japan; Nephrotic Syndrome; Practice Guidelines as Topic; Prednisolone; Prognosis; Ribonucleosides; Surveys and Questionnaires; Time Factors | 2002 |
[Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Ribonucleosides; Tacrolimus | 2004 |
Non-corticosteroid treatment for nephrotic syndrome in children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Infant; Levamisole; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Ribonucleosides; Secondary Prevention | 2008 |
Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
Topics: Cyclosporine; Diagnosis, Differential; Female; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 1993 |
Mizoribine and mycophenolate mofetil.
Topics: Animals; Arthritis; Carbon-Nitrogen Ligases; Cell Cycle; Cell Division; Clinical Trials as Topic; Creatine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kinetics; Lupus Nephritis; Lymphocytes; Mice; Mitogens; Models, Biological; Models, Chemical; Mycophenolic Acid; Nephrotic Syndrome; Organ Transplantation; Ribonucleosides; Time Factors; Tumor Cells, Cultured | 1999 |
Nephrotic syndrome and mizoribine in children.
Topics: Animals; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence; Ribonucleosides | 2002 |
10 trial(s) available for mizoribine and Nephrotic Syndrome
| Article | Year |
|---|---|
Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Ribonucleosides; Steroids | 2018 |
Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisone; Proteinuria; Remission Induction; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2013 |
Effects of probenecid on the pharmacokinetics of mizoribine and co-administration of the two drugs in patients with nephrotic syndrome.
Topics: Adult; Aged; Female; Half-Life; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Probenecid; Ribonucleosides; Uricosuric Agents | 2010 |
Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Topics: Adolescent; Child; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Pilot Projects; Prednisone; Ribonucleosides; Tacrolimus; Young Adult | 2011 |
Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome | 2012 |
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Topics: Adult; Drug Resistance; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Patient Dropouts; Product Surveillance, Postmarketing; Proteinuria; Remission Induction; Ribonucleosides; Steroids | 2004 |
[Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Topics: Adolescent; Adult; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Retrospective Studies; Ribonucleosides | 2006 |
Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; IMP Dehydrogenase; Incidence; Leukocyte Count; Male; Nephrotic Syndrome; Prednisolone; Ribonucleosides; Secondary Prevention; Treatment Outcome; Uric Acid | 2008 |
Mizoribine in steroid-dependent nephrotic syndrome of childhood.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 1997 |
A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Placebos; Prednisolone; Ribonucleosides; Secondary Prevention | 2000 |
21 other study(ies) available for mizoribine and Nephrotic Syndrome
| Article | Year |
|---|---|
Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.
Topics: Child; Child, Preschool; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Recurrence; Retrospective Studies; Ribonucleosides; Steroids | 2022 |
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?
Topics: Age Factors; Child; Cyclophosphamide; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Ribonucleosides; Risk Assessment; Risk Factors; Rituximab; Time Factors; Treatment Outcome | 2020 |
Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Biopsy; Comorbidity; Drug Therapy, Combination; Edema; Female; Glomerulonephritis, Membranoproliferative; Humans; IgA Vasculitis; Immunoglobulin A; Immunosuppressive Agents; Kidney; Leg; Nephrotic Syndrome; Remission Induction; Ribonucleosides; Vasculitis | 2021 |
Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Topics: Adolescent; Age of Onset; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Ribonucleosides; Steroids; Time Factors; Treatment Outcome | 2019 |
Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study.
Topics: Adolescent; Calcineurin Inhibitors; Child; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Nephrotic Syndrome; Pulse Therapy, Drug; Recurrence; Remission Induction; Ribonucleosides; Rituximab; Treatment Outcome | 2019 |
Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.
Topics: Adolescent; Child; Child, Preschool; China; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Ribonucleosides | 2019 |
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles | 2013 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Safety and efficacy of mizoribine treatment in nephrotic syndrome complicated with hepatitis B virus infection: a clinical study.
Topics: Adult; Antiviral Agents; Drug Monitoring; Enzyme Inhibitors; Female; Guanine; Hepatitis B, Chronic; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Nephrotic Syndrome; Ribonucleosides; Treatment Outcome | 2016 |
Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis.
Topics: Administration, Oral; Adult; Blood Component Removal; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisone; Pulse Therapy, Drug; Ribonucleosides | 2008 |
Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Topics: Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome | 2011 |
Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome.
Topics: Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Humans; Immunosuppressive Agents; Infant; Maintenance Chemotherapy; Male; Nephrotic Syndrome; Ribonucleosides; Steroids | 2012 |
Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Child; Female; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome | 2005 |
Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
Topics: Child; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 2005 |
Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Ribonucleosides | 2005 |
High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Topics: Adolescent; Adult; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Ribonucleosides; Secondary Prevention; Time Factors; Treatment Outcome | 2005 |
[Treatment guidelines for the idiopathic nephrotic syndrome in children].
Topics: Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides | 2005 |
Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.
Topics: Brain Diseases; Child, Preschool; Cyclosporine; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Plasmapheresis; Pulse Therapy, Drug; Radiography; Ribonucleosides; Time Factors; Treatment Outcome | 2007 |
Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Energy Metabolism; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Intracellular Membranes; Kidney Glomerulus; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Nephrotic Syndrome; Podocytes; Protein Processing, Post-Translational; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Ribonucleosides; RNA, Messenger; Stress, Physiological | 2007 |
A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Humans; Lupus Nephritis; Male; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 2008 |
Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.
Topics: Child; Child, Preschool; Combined Modality Therapy; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Ribonucleosides | 1994 |